9 min listen
Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases
FromHeart podcast
Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases
FromHeart podcast
ratings:
Length:
24 minutes
Released:
Oct 15, 2021
Format:
Podcast episode
Description
In this episode of the Heart podcast, Digital Media Editor, Dr James Rudd, is joined by Dr Guarav Gulsin from the University of British Columbia. They cover everything you need to know about this class of drugs for use in heart disease and beyond following the publication of a comprehensive review paper in Heart.
If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper:
https://heart.bmj.com/content/early/2021/05/09/heartjnl-2021-319185
If you enjoy the show, please subscribe to the podcast to get episodes automatically downloaded to your phone and computer. Also, please consider leaving us a review at https://itunes.apple.com/gb/podcast/heart-podcast/id445358212?mt=2
Link to published paper:
https://heart.bmj.com/content/early/2021/05/09/heartjnl-2021-319185
Released:
Oct 15, 2021
Format:
Podcast episode
Titles in the series (100)
Tissue engineering for mending a broken heart: Following on from their sessions at the British C… by Heart podcast